JILL FERRETTI: Open Payments
NPI 1093490161 · NANTICOKE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,122 in 156 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $2,247 · 2025 $3,122
Food & beverage: $3,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $467 |
| Madrigal Pharmaceuticals | 12 | $456 |
| Phathom Pharmaceuticals, Inc. | 22 | $415 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $299 |
| Ardelyx, Inc. | 14 | $293 |
| Aimmune Therapeutics, Inc. | 18 | $267 |
| Regeneron Healthcare Solutions, Inc. | 8 | $267 |
| Janssen Biotech, Inc. | 19 | $213 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $143 |
| Lilly USA, LLC | 1 | $115 |
Products named: REZDIFFRA, VOQUEZNA, IBSRELA, DUPIXENT, XIFAXAN, ZENPEP, TREMFYA, RINVOQ.
Industry payments across PA — which companies pay providers there.
